Tag: UTULY (BRYN-NDS1C)
FDA Denies Approval of Needle-Free Alternative to Epinephrine Auto-injectors
The rejection was unexpected based on feedback from the FDA's expert panel in June.
Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...
Company is developing UTULY for intranasal emergency epinephrine delivery.
Bryn Shows UTULY™ Intranasal Epinephrine Absorbs Faster and is Sustained Longer...
A needleless, self administered nasal spray intended to be used in anaphylactic emergencies in place of traditional auto-injectors.
Bryn Pharma Completes Study of Nasal Epinephrine vs Auto-Injector for Anaphylaxis
Nasal administration of epinephrine takes another step forward.
They’re Coming: Needle-Free Emergency Epinephrine Options Currently in Trials
For some, the needle is a barrier to administration but alternatives are on the horizon.
CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...
The market for epinephrine delivery may expand to include non-needle alternatives next year.
Intranasal Epinephrine to Take Center Stage at 2022 AAAAI Annual Meeting
Emergency epinephrine without the jab makes strides.
Bryn Pharma Research on Epinephrine Nasal Spray Presented at ACAAI Annual...
Two studies shed light on the viability of intranasal delivery of emergency epinephrine.
